CaaS Capital Management

CaaS Capital Management is a global investment manager specializing in the healthcare and biopharmaceutical sectors. The firm focuses on providing capital across various stages, including Series B, Series C, Series D, Post IPO Equity, and Private Placement VC, with investments ranging from $1 million to $50 million. Their geographical focus includes the United States and the United Kingdom, with a particular emphasis on the healthcare and biopharmaceutical industries.

The firm's investment strategy combines fundamental and quantitative analyses to identify promising opportunities. They prioritize transparent communication and a commitment to their partners, aiming to provide liquidity and capital as a service. CaaS Capital Management has a proven track record in the healthcare sector, with investments in companies such as Umoja Biopharma.

CaaS Capital Management is headquartered in New York, NY, and maintains an active presence in the United Kingdom. The firm is led by a team of experienced professionals, including Frank Fu, the founder and portfolio manager, and Ryan Huang, a quantitative trader. Their collective expertise supports the firm's mission to deliver innovative investment solutions in the healthcare and biopharmaceutical sectors.